ABSTRACT: The continuous, real-time monitoring of specific molecular targets in unprocessed clinical samples would enable many transformative medical applications. Electrochemical aptamer-based (E-AB) sensors appear to be a promising approach to this end because of their selectivity (performance in complex samples, such as serum) and reversible, single-step operation. E-AB sensors suffer, however, from often-severe baseline drift when challenged in undiluted whole blood. In response we report here a dual-reporter approach to performing E-AB baseline drift correction. The approach incorporates two redox reporters on the aptamer, one of which serves as the target-responsive sensor and the other, which reports at a distinct, nonoverlapping redox potential, serving as a driftcorrecting reference. Taking the difference in their relative signals largely eliminates the drift observed for these sensors in flowing, undiluted whole blood, reducing drift of up to 50% to less than 2% over many hours of continuous operation under these challenging conditions. A major goal of bioanalytical chemistry has been the development of platforms supporting the rapid and convenient measurement of specific molecules directly in unprocessed clinical samples or even when deployed in situ in the body.
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ABSTRACT: The continuous, real-time monitoring of specific molecular targets in unprocessed clinical samples would enable many transformative medical applications. Electrochemical aptamer-based (E-AB) sensors appear to be a promising approach to this end because of their selectivity (performance in complex samples, such as serum) and reversible, single-step operation. E-AB sensors suffer, however, from often-severe baseline drift when challenged in undiluted whole blood. In response we report here a dual-reporter approach to performing E-AB baseline drift correction. The approach incorporates two redox reporters on the aptamer, one of which serves as the target-responsive sensor and the other, which reports at a distinct, nonoverlapping redox potential, serving as a driftcorrecting reference. Taking the difference in their relative signals largely eliminates the drift observed for these sensors in flowing, undiluted whole blood, reducing drift of up to 50% to less than 2% over many hours of continuous operation under these challenging conditions. A major goal of bioanalytical chemistry has been the development of platforms supporting the rapid and convenient measurement of specific molecules directly in unprocessed clinical samples or even when deployed in situ in the body. 1−5 Toward this goal we, 6, 7 and others, 8 have previously described a broad class of electrochemical aptamer-based (E-AB) sensors for the detection of proteins, small molecules, and inorganic ions.
9 E-AB sensors are comprised of an electrode-bound, redox reporter-modified aptamer that undergoes a binding-induced conformational change ( Figure 1 ). This conformational change alters the positioning of the reporter relative to the electrode, producing a target-dependent change in current when the sensor is interrogated using square wave voltammetry. The reagentless, reversible nature of this signal transduction mechanism renders E-AB sensors capable of supporting continuous monitoring. 10 And because it mimics the conformation-linked signaling that occurs in natural chemoperception systems, 11 this mechanism also renders E-AB sensors among the most selective single-step biosensors reported to date, allowing for their multihour operation, for example, in undiluted blood serum.
9,12,13 E-AB sensors suffer, however, from significant baseline drift when deployed directly in whole blood, likely due to the adherence of blood cells onto the electrode. 14 In response, we demonstrate here a new solution to this baseline drift problem.
Our new approach to E-AB drift correction is analogous to a "dual-reporter" mechanism previously demonstrated for optical (fluorescent) sensors. 15−22 In this a sensor's recognition "probe" is modified with two fluorophores reporting at distinct, nonoverlapping wavelengths. While both are responsive to environmental effects, instrumental artifacts, and variations in probe concentration, only one responds to the target. The other then serves as a reference that can be used to correct for these background effects, improving measurement accuracy and stability. Previously, the Ellington group has used an analogous approach to correct for sensor-to-sensor fabrication variability in electrochemical DNA-type sensors. 23 Following this we describe here a dual-reporter approach to performing E-AB baseline-drift correction that enables continuous, real-time, long-duration measurements of specific molecules directly in flowing whole blood.
Our approach to drift correction relies on the use of two redox reporters conjugated to each aptamer probe (Figure 1 ), a Here we describe a dual-reporter approach to perform baseline drift correction for E-AB sensors. To achieve this the aptamer is modified via the attachment of two redox reporters reporting at distinct, nonoverlapping potentials (here methylene blue, MB, and anthraquinone, AQ). The first, the sensing reporter, is placed at the distal end of the aptamer such that its output responds to any bindinginduced conformational changes. The second, the reference reporter, is placed at the electrode-proximal end of the aptamer such that its positioning relative to the electrode, and thus its output current is relatively insensitive to target binding, but it is equally sensitive to matrix effects responsible for signaling drift.
sensing reporter, here methylene blue (MB), and a reference reporter, here anthraquinone (AQ). We selected these reporters for three reasons. First, their potentials do not overlap, allowing for the simultaneous monitoring of both. Second, both are reasonably stable. 24 And, finally, their physical properties are sufficiently similar that they respond in concert to the environmental changes that cause drift. To perform drift correction we placed the sensing reporter (i.e., MB) on the distal end (away from the electrode) of the aptamer. In this position the efficiency with which it approaches the electrode to transfer electrons depends sensitively on the (binding-defined) conformation of the aptamer. We placed the reference reporter (i.e., AQ), in contrast, on the nucleobase proximal to the electrode, rendering its distance from the electrode largely independent of the aptamer's conformation. Thus, while both reporters respond to the environmental effects that cause drift, only the sensing reporter also responds to the target.
Motivated by the argument that monitoring drug levels is a particularly important application of in-blood measurements we used a sensor employing the cocaine-binding aptamer of Stojanovic 25, 26 as our first test bed. We modified the distal end of the aptamer with MB and its proximal end with AQ. Using square wave voltammetry to interrogate the resultant sensor in phosphate-buffered saline (PBS) we observed redox peaks at −0.26 V and −0.42 V, corresponding to the reduction of MB and AQ respectively ( Figure 2A ). As expected, the current originating from the MB reporter increases significantly and monotonically upon spiking with increasing concentrations of cocaine. The current from the AQ reporter, in contrast, is largely insensitive to the target, suggesting that it might prove a suitable drift-correction reference.
To test the ability of the AQ reporter to provide stable drift correction we first challenged a set of these cocaine-detecting sensors in flowing, undiluted whole blood using an in vitro system meant to mimic circulation in the vasculature ( Figure  S1 ). Over the course of 15 h in flowing whole blood the currents arising from both MB and AQ drift by 25%−30% ( Figure 2B ). The two currents, however, drift in concert, as required for dual-reporter drift correction. To perform such a correction, we calculate the change in relative currents from
in which S cor is the corrected relative signal change, i MB and i AQ are the peak currents from the MB and AQ, respectively, and i MB0 and i AQ0 are the peak currents collected in the absence of target at the first data point in each experiment. In sharp contrast to the raw MB and AQ currents, the drift in S cor is less than 2% after 15 h (green trace, Figure 2B ). And while the drift in raw current observed for individual sensors often varies dramatically (presumably due to the stochastic formation of macroscopic aggregates of blood cells on the sensor surface), the drift correction is quite reproducible ( Figure S2 ). Dual-reporter baseline correction also corrects for sensor drift when the sensor is being challenged with its specific molecular target. To demonstrate this we tested dual-reporter cocaine sensors against varying pulses of the drug in flowing whole blood over the course of several hours. In both the presence and absence of target we again observe significant (∼10% per hour), continuous drift in both the MB and AQ currents ( Figure 2C ). In contrast, S cor and, from that, the predicted concentration drift far less ( Figure 2D ).
To determine whether dual-reporter drift correction is general, we next characterized E-AB sensors employing dualmodified aptamers binding the aminoglycoside antibiotics 27 and the cancer chemotherapeutic doxorubicin.
14 In contrast to the cocaine-binding aptamer, which adopts a trefoil fold, 27 these aptamers fold into a hairpin structure, 28, 14 thus providing further insights into the generality (aptamer-independence) of our approach. Once again we modified each with an MB on its distal end and an AQ on its proximal end.
The dual-reporter approach effectively corrects baseline drift for both aminoglycoside-and doxorubicin-detecting sensors. Upon challenging the former in buffer with kanamycin, for example, we find that the current from the MB reporter increases significantly while that from the AQ reporter increases by less than 5% ( Figure 3A) . Upon challenging it in flowing whole blood for 20 h the currents from both reporters drift by 15%−20%, which is reduced to less than 2% upon correction ( Figure 3B ). We then tested the sensor against varying pulses of kanamycin in flowing whole blood, finding that both currents drift by ∼7% per hour and also exhibit discontinuous "jumps" of order 25% when removed from drug-containing whole blood and returned to a drug-free sample ( Figure 3C ). Again, however, dual-reporter drift correction reduces the drift in estimated drug concentration to less than 2% per hour and effectively eliminates the jumps seen upon transfer ( Figure 3D ). The dual-reporter approach also effectively corrects baseline drift for the doxorubicin sensor, reducing a drift of more than 50% over 8 h to less than 5% ( Figure S8 ). Unfortunately, however, doxorubicin is redox active at the same potential as AQ and thus we were precluded from studying the performance of this sensor in the presence of its target.
Here we have demonstrated a dual-reporter approach to performing baseline drift correction for E-AB sensors. The approach largely eliminates the drift seen when E-AB sensors are deployed directly in flowing, undiluted whole blood, reducing drift in the raw electrochemical signals of up to 50% to less than 5% over many hours. Moreover, the approach corrects both the steady drift seen in flowing blood and the dramatic jumps in signal seen when the sensor is physically moved into a fresh sample. Given these results we are optimistic that, by analogy to the optical counterpart that inspired it, dual-reporter drift correction will be applicable to a wide variety of electrochemical sensor architectures.
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